SynergyMed
Early Stage
The non-surgical solution for the treatment of cancer tumors
Overview
Platform
OurCrowd
Start Date
10/09/2022
Close Date
05/24/2023
Min. Goal
$10,000
Max. Goal
$2,800,000
Min. Investment
$10,000
Security Type
Equity - Common
Series
Pre-Seed
SEC Filing Type
RegD 506(c)
Pre-Money Valuation
$18,500,000
Year Founded
2018
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
SynergyMed, with a valuation of $18.5 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company has developed a medical 3D visualization and printing platform to design and 3D print patient-specific surgical tools and implants. The proprietary software-only platform of SynergyMed is hardware agnostic and can be used with any printer. The technology has already been used for 1,200 surgical procedures across 16 surgical disciplines, and plans to expand to the US and receive FDA approval. Anan Copty and Rob Roy founded SynergyMed in January 2018. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $2.8 million. The campaign proceeds will be used to expand into the US market and continue to develop the software.
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.